Targeting novel cell survival programs in AML regulated by Phosphoinositide 3-kinase.

  • Guthridge, Mark (Primary Chief Investigator (PCI))
  • Layton, Meredith (Chief Investigator (CI))
  • Ekert, Paul (Partner Investigator (PI))
  • Lopez, Angel (Partner Investigator (PI))
  • Shepherd, Peter (Partner Investigator (PI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1131/12/11

Funding

  • Leukaemia Foundation: AUD99,736.00